|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| Revenue - License Fee: | |||
| Operating expenses: | |||
| Research and development | |||
| General and administrative | |||
| Total operating expenses | |||
| Loss from operations | |||
| Other income: | |||
| (Loss) gain from foreign exchange | |||
| Interest and other income, net | |||
| Other income, net | |||
| Net loss | |||
| Net loss per share, basic and diluted | |||
| Weighted-average number of shares used to compute net loss per share, basic and diluted | |||
| Net loss per share, basic | |||
| Net loss per share, diluted | |||
| Weighted average shares used to compute net loss per share, basic | |||
| Weighted average shares used to compute net loss per share, diluted | |||
| Unrealized gain on available-for-sale securities | |||
| Comprehensive loss |
Loading...
